跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Oxestal-20
Approved
STANDARD
Oxestal-20
Stallion Laboratories Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
430849490b6065e9
Company
Stallion Laboratories Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
430849490b6065e9
Drug Approval Philippines Name
Oxestal-20
Product Name
Oxestal-20
Registration Number
DRP-13035
Brand Name
Oxestal-20
Generic Name
Fluoxetine
Dosage Form
Capsule
Dosage Strength
20 mg
Manufacturer
Stallion Laboratories Pvt. Ltd.
Importer
Ambica International Corporation
Distributor
Ambica International Corporation
Issuance Date
24 November 2022
Expiry Date
24 November 2027
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
430849490b6065e9
Type
Standard
Back to Philippines FDA Approvals
Oxestal-20 - Philippines FDA Drug Approval Details